Sanara MedTech Inc. Announces Changes to Board of Directors
Fort Worth, TX, Oct. 07, 2024 (GLOBE NEWSWIRE) — Sanara MedTech Inc.
Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound, and skincare markets announced today changes to its Board of Directors (“Board”).
Board Transition
After a long tenure of service with the predecessor company and Sanara, Mr. James “Jim” Stuckert has resigned from his position as a director. In order to fill the vacancy resulting from Mr. Stuckert’s resignation, Mr. Keith Myers has been appointed to serve as a director on the Board. Mr. Stuckert will continue to serve the Board as Director Emeritus.
Mr. Stuckert’s contribution to the company has been invaluable over the years, and his transition to Director Emeritus signifies a continued commitment to Sanara’s mission and vision. Meanwhile, the appointment of Mr. Myers brings new perspectives and experience to the Board, further strengthening Sanara’s leadership team.
Sanara MedTech Inc. remains dedicated to driving innovation in healthcare and enhancing patient care through its cutting-edge medical technologies. The changes to the Board of Directors reflect the company’s ongoing evolution and commitment to excellence in the medical technology industry.
How This Will Affect Me
As a shareholder or investor in Sanara MedTech Inc., the changes to the Board of Directors may have implications for the company’s strategic direction and long-term performance. It is important to stay informed about the new appointments and how they may impact the company’s growth trajectory.
How This Will Affect the World
Sanara MedTech Inc.’s focus on improving clinical outcomes and reducing healthcare expenditures aligns with global efforts to enhance patient care and make healthcare more accessible and affordable. The changes to the Board of Directors may influence the company’s ability to drive innovation and advance medical technologies that benefit patients worldwide.
Conclusion
The changes to Sanara MedTech Inc.’s Board of Directors mark a significant moment in the company’s evolution, signaling a continued commitment to excellence in the medical technology industry. With a renewed leadership team and a focus on innovation, Sanara is poised to make a positive impact on healthcare and patient outcomes in the years to come.
